光动力疗法联合药物治疗日光性角化病的有效性与安全性
作者:
作者简介:

张雪洁(1986.12-),女,山东济宁人,硕士,主治医师,主要从事皮肤病与性病的诊断及治疗方面工作

中图分类号:

R758.1


Efficacy and Safety of Photodynamic Therapy Combined with Drugs in the Treatment of Actinic Keratosis
Author:
  • 摘要
  • | |
  • 访问统计
  • |
  • 参考文献 [15]
  • |
  • 相似文献 [20]
  • | | |
  • 文章评论
    摘要:

    目的 探究光动力疗法联合药物治疗日光性角化病的有效性与安全性。方法 选择2022年 1月-2023年12月济宁市皮肤病防治院收治的60例日光性角化病患者为研究对象,采用随机数字表法分为 对照组与观察组,每组30例。对照组予以咪喹莫特治疗,观察组予以光动力疗法联合药物治疗,比较两 组皮损情况、治疗效果、不良反应发生情况及复发率。结果 两组治疗后皮损面积、数量低于治疗前,且 观察组低于对照组(P<0.05);观察组治疗总有效率为96.67%,高于对照组的73.33%(P<0.05);观察组 不良反应发生率为3.33%,低于对照组的20.00%(P <0.05);观察组复发率为3.33%,低于对照组的23.33% (P <0.05)。结论 针对日光性角化病患者采用光动力疗法联合药物治疗,能有效缩小皮损面积,提升治 疗效果,降低不良反应发生率及疾病复发率,值得临床应用。

    Abstract:

    Objective To explore the efficacy and safety of photodynamic therapy combined with drugs in the treatment of actinic keratosis. Methods A total of 60 patients with actinic keratosis admitted to Jining Dermatosis Prevention and Treatment Hospital from January 2022 to December 2023 were selected as the research subjects, and they were divided into the control group and the observation group by the random number table method, with 30 patients in each group. The control group was treated with imiquimod, and the observation group was treated with photodynamic therapy combined with drugs. The skin lesions, treatment effect, adverse reactions and recurrence rate were compared between the two groups. Results After treatment, the skin lesion area and number in the two groups were lower than those before treatment, and those in the observation group were lower than those in the control group (P <0.05). The total effective rate of treatment in the observation group was 96.67%, which was higher than 73.33% in the control group (P <0.05). The incidence of adverse reactions in the observation group was 3.33%, which was lower than 20.00% in the control group (P <0.05). The recurrence rate in the observation group was 3.33%, which was lower than 23.33% in the control group (P <0.05). Conclusion The application of photodynamic therapy combined with drugs in the treatment of patients with actinic keratosis can effectively reduce the skin lesion area, improve the treatment effect, and reduce the incidence of adverse reactions and the recurrence rate of the disease, which is worthy of clinical application.

    参考文献
    [1]付秀娟,黄茜,叶静,等.5-氨基酮戊酸光动力疗法联合CO2 点阵激光治疗日光性角化病的疗效观察[J].中国中西医 结合皮肤性病学杂志,2023,22(2):138-140.
    [2]姜梦英,贺爱娟.疣状盘状红斑狼疮合并光化性扁平苔藓及 日光性角化病1例[J].医学理论与实践,2024,37(20):3520- 3521,3562.
    [3]李泓馨,管海宏,孙建方,等.肿瘤干细胞标志物ABCG2、 C K 1 9和P63在皮肤日光性角化病、Bowen病及鳞 状细胞癌中的表达差异及意义[ J ] . 解放军医学杂 志,2012,37(6):623-627.
    [4]任晓宇,张铁民,侯保金.全飞秒激光近视手术透镜瓣移 植修补结膜日光性角化病切除后组织缺损一例[J].眼 科,2021,30(4):319-320.
    [5]王智文,周丹,仇春燕,等.机械磨削术联合光动力疗法治 疗面部日光性角化病疗效观察及护理[J].中国美容医 学,2021,30(6):98-100.
    [6]于浩杰,马海丽.对日光性角化病患者实施健康教育与 皮肤鳞状细胞癌认知度的相关性分析[J].中国基层医 药,2022,29(2):304-306.
    [7]马委委,鲁严,周炳荣.光动力疗法在皮肤老化治疗中的基 础和临床研究进展[J].实用老年医学,2020,34(1):6-9.
    [8]高尧颖,杨井,陶娟.皮肤影像技术在日光性角化病诊疗中 的应用价值[J].中国医刊,2022,57(9):947-949.
    [9]郭美亮,刘婉雯,孟琴琴,等.沉默信息调节蛋白3在日光性 角化病和皮肤鳞状细胞癌中的表达及意义[J].中国中西 医结合皮肤性病学杂志,2022,21(3):211-214.
    [10]易勤,刘珈言,梅蓉,等.光动力联合咪喹莫特治疗日光性 角化病临床疗效研究[J].中国美容医学,2022,31(1):58- 61.
    [11]刘冬梅,蒋亦秀,张优拉,等.热休克蛋白10、60在皮肤鳞 状细胞癌、基底细胞癌、日光性角化病中的表达[J].中 华皮肤科杂志,2011,44(2):106-109.
    [12]张倩,张珂,布文博,等.皮肤镜在日光性角化病诊断中的 应用价值探讨[J].中国美容医学,2018,27(9):13-15.
    [13]李昕,朱建建,何平,等.53例面部日光性角化病皮肤镜及 病理特征分析[J].皮肤科学通报,2023,40(3):279-285.
    [14]汪静文,王静,王娜,等.CO2点阵激光预处理联合光动力 疗法治疗日光性角化病临床疗效观察[J].蚌埠医学院学 报,2023,48(7):925-928.
    [15]舒心,杨怡,孙杰,等.5-氨基酮戊酸光动力疗法治疗鲍温 样型日光性角化病1例[J].武警医学,2022,33(8):718-719.
    引证文献
    网友评论
    网友评论
    分享到微博
    发 布
引用本文

张雪洁,张岩.光动力疗法联合药物治疗日光性角化病的有效性与安全性[J].医学美学美容,2025,34(5):85-.

复制
分享
文章指标
  • 点击次数:14
  • 下载次数: 31
  • HTML阅读次数: 0
  • 引用次数: 0
历史
  • 在线发布日期: 2025-03-31